[Digestive adverse effects due to sodium polystyrene sulfonate (Kayexalate) in dialysis patients].
Administered to reduce hyperkaliema in patients with chronic renal failure, sodium polystyrene sulfonate (Kayexalate) can cause digestive complications. The most severe complication could be the intestinal necrosis or perforation. In the present report, we evoke these complications and illustrate them with some pictures from personal observations.